Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87,785Revenue $M26,095Net Margin (%)4.9Altman Z-Score2.1
Enterprise Value $M93,165EPS $1.0Operating Margin %8.6Piotroski F-Score3
P/E(ttm)70.7Beneish M-Score-2.9Pre-tax Margin (%)4.9Higher ROA y-yN
Price/Book5.010-y EBITDA Growth Rate %4.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %-16.2Current Ratio0.8Lower Leverage y-yN
Price/Free Cash Flow34.9y-y EBITDA Growth Rate %-34.0ROA % (ttm)2.2Higher Current Ratio y-yN
Dividend Yield %4.0PEG--ROE % (ttm)6.3Less Shares Outstanding y-yN
Payout Ratio %277Shares Outstanding M1,264ROIC % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDavid Dreman 2015-03-31 Reduce-0.01%$64.44 - $72.7
($69.48)
$ 69.45-0%Reduce 4.43%27,489
AZNNWQ Managers 2015-03-31 Reduce-0.01%$64.44 - $72.7
($69.48)
$ 69.45-0%Reduce 21.34%52,265
AZNMario Gabelli 2015-03-31 Reduce$64.44 - $72.7
($69.48)
$ 69.45-0%Reduce 40.70%11,800
AZNDavid Dreman 2014-12-31 Reduce-0.51%$67.15 - $75.38
($71.66)
$ 69.45-3%Reduce 75.42%28,764
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$67.15 - $75.38
($71.66)
$ 69.45-3%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$67.15 - $75.38
($71.62)
$ 69.45-3%Reduce 52.51%19,900
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$68.49 - $76.31
($73.2)
$ 69.45-5%Sold Out0
AZNCharles Brandes 2014-06-30 Reduce-0.78%$62.45 - $81.09
($72.26)
$ 69.45-4%Reduce 71.06%386,058
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$62.45 - $81.09
($72.26)
$ 69.45-4%Sold Out0
AZNGeorge Soros 2014-06-30 Buy 0.08%$62.45 - $81.09
($72.26)
$ 69.45-4%New holding150,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$62.45 - $81.09
($72.26)
$ 69.45-4%New holding40,400
AZNNWQ Managers 2014-06-30 Reduce-0.01%$62.45 - $81.09
($72.26)
$ 69.45-4%Reduce 24.55%64,475
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$58.51 - $68.38
($64.41)
$ 69.458%Sold Out0
AZNCharles Brandes 2014-03-31 Reduce-0.84%$58.51 - $68.15
($64.29)
$ 69.458%Reduce 46.73%1,333,894
AZNDavid Dreman 2014-03-31 Add0.14%$58.51 - $68.38
($64.41)
$ 69.458%Add 26.61%135,439
AZNJoel Greenblatt 2014-03-31 Buy 0.09%$58.51 - $68.38
($64.41)
$ 69.458%New holding95,518
AZNDavid Dreman 2013-12-31 Reduce-0.34%$49.72 - $59.5
($54.28)
$ 69.4528%Reduce 40.32%106,975
AZNHOTCHKIS & WILEY 2013-12-31 Reduce-0.3%$49.72 - $59.5
($54.28)
$ 69.4528%Reduce 24.90%3,689,214
AZNCharles Brandes 2013-09-30 Add0.12%$47.88 - $52.08
($50.24)
$ 69.4538%Add 7.92%2,381,040
AZNHOTCHKIS & WILEY 2013-06-30 Add0.68%$47.22 - $53.01
($50.92)
$ 69.4536%Add 131.18%4,944,742
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$17308.53view

Press Releases about AZN :

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
    Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 
    Brandes International Equity Fund Q3 Commentary Dec 23 2014 
    Blackhill Bets Almost Half of Portfolio on Williams-Sonoma Nov 10 2014 
    A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio Nov 09 2014 
    Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 

    More From Other Websites
    Amgen Ends Psoriasis-Drug Partnership With AstraZeneca May 22 2015
    Amgen ends partnership with AstraZeneca on psoriasis drug May 22 2015
    Amgen ends partnership with AstraZeneca on psoriasis drug May 22 2015
    Amgen ends work on experimental psoriasis drug May 22 2015
    Amgen ends work on experimental psoriasis drug May 22 2015
    Amgen ends collaboration with AstraZeneca on inflammation drug May 22 2015
    Amgen ends collaboration with AstraZeneca on inflammation drug May 22 2015
    AstraZeneca provides update on brodalumab development programme May 22 2015
    Amgen to terminate participation in co-development and commercialization of brodalumab May 22 2015
    Startup AdverseEvents makes side effects a factor in the cost of a drug May 22 2015
    Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy May 22 2015
    In a quiet stock market, whispers of an M&A wave May 22 2015
    All Eyes on Pfizer as Shareholders Await the Mega-Deal: Real M&A May 21 2015
    Olympic Gold Medalist Jackie Joyner-Kersee Teams up with AstraZeneca to Raise Awareness about... May 20 2015
    Houston, Johnson & Johnson May Have a Problem May 19 2015
    Shire Has Outperformed AstraZeneca After Acquisition Bids For Both Failed To Materialize May 19 2015
    AstraZeneca Reports Data from KODIAC studies on Movantik - Analyst Blog May 18 2015
    Endo pushes further into generics with $8 bln Par Pharma buy May 18 2015
    5 Dividend Darlings Poised To Take Off: AstraZeneca plc, RSA Insurance Group plc, Cobham plc, N... May 18 2015
    AstraZeneca to invest £182m to expand drug plant in Sweden May 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK